Article(id=1329914644648538520, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914644128444824, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2024.07.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1693238400000, receivedDateStr=2023-08-29, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795005959903, onlineDateStr=2026-11-18, pubDate=1720540800000, pubDateStr=2024-07-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795005959903, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795005959903, creator=13701087609, updateTime=1795005959903, updator=13701087609, issue=Issue{id=1329914644128444824, tenantId=1146029695717560320, journalId=1319690259887390882, year='2024', volume='55', issue='7', pageStart='887', pageEnd='1044', issueExtLink='null', onlineDate='null', pubDate='1720540800000', pubDateStr='2024-07-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795005959779, creator='13701087609', updateTime=1795136174555, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330460804954043169, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914644128444824, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330460804954043170, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914644128444824, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=887, endPage=899, ext={EN=ArticleExt(id=1329914644887613849, articleId=1329914644648538520, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Application of Morphologically-directed Raman Spectroscopy in the Bioequivalence Study of Suspension-based Nasal Spray, columnId=1327671169563603616, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Perspectives, runingTitle=null, highlight=null, articleAbstract=

Bioequivalence studies of suspension-based nasal sprays are challenging tasks for generic drug developers. Researchers should not only conduct consistency studies on the dosage and formulation characteristics of excipients in accordance with the requirements of the guidelines, but also need to use analytical tools to determine the consistency of key quality attributes such as particle size and particle size distribution of active pharmaceutical ingredients. This study explored the application of morphologically-directed Raman spectroscopy in the study of particle size distribution of nasal suspensions. The method has been approved by the U.S. FDA for the studies that substitute bioequivalence of clinical endpoints, which is critical for cost reduction and faster development for consistency evaluation of suspension-based nasal spray products.

, authors=Li WANG1, Lili ZHOU2, Yang LIU3, Qi SHAO3, *, authorsList=Li WANG, Lili ZHOU, Yang LIU, Qi SHAO, authorCompany=null, correspAuthors=Qi SHAO, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329914646154293660, articleId=1329914644648538520, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=形态定向拉曼光谱检测在混悬型鼻喷剂生物等效性研究中的应用, columnId=1327671169823650466, journalTitle=中国医药工业杂志, columnName=专论, runingTitle=null, highlight=null, articleAbstract=

混悬型鼻用喷雾剂的生物等效性研究对于仿制药开发者而言是一项具有挑战性的任务。研究者不仅要按照指导原则的要求,对辅料用量和制剂特性进行一致性研究,更需要通过分析工具来确定活性药物成分的粒径大小、粒度分布等关键质量属性的一致性。该文探讨了形态定向拉曼光谱法在研究鼻腔悬浮液粒度分布中的应用。该方法已被美国FDA批准用于替代临床终点生物等效性的研究,对降低混悬型鼻用喷雾剂类产品一致性评价的成本、加快其研发速度有重要作用。

, authors=王力1, 周丽丽2, 刘洋3, 邵奇3, *, authorsList=王力, 周丽丽, 刘洋, 邵奇, authorCompany=null, correspAuthors=邵奇, authorNote=

邵奇,高级工程师,市级青年领军人才。2008年入职上药信谊药物研究所,现担任所长助理。曾荣获全国五一劳动奖章,市级以上相关荣誉5项。现兼职担任中国颗粒学会吸入颗粒专业委员会秘书长、上海理工大学硕士生导师等职务。主要研究方向为吸入制剂、注射液、口服液等产品的研发与产业化工作。在职期间,带领团队获国家药品监督管理局批准产品生产批件共计10项,其中气雾剂4项,雾化吸入剂2项,注射液4项;吸入制剂临床批件2项;其他在研吸入制剂(含鼻喷)6项,口服混悬液1项,软胶囊制剂2项等。在美国FDA完成申报鼻喷剂项目1项。作为第二主译参与《经口吸入产品的级联撞击器理论与实践》的编译、出版。国家授权专利11项。

王力(1996—),男,硕士,从事吸入及鼻喷制剂的研究。

, correspAuthorsNote=
邵奇(1986—),男,硕士生导师,从事吸入及液体制剂的研究与开发。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=rRix4BVTapg45MI3Pe2A0g==, magXml=/WH/F3AmWPEu1VxTMMnURg==, pdfUrl=null, pdf=JjwzebHA/2RSH7T2/7QxFw==, pdfFileSize=4194325, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=9iA2/OHpw4wooIxYASM01Q==, mapNumber=null, fund=null)}, authors=[Author(id=1329914646594695591, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914646657610153, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, authorId=1329914646594695591, language=EN, stringName=Li WANG, firstName=Li, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Shanghai Pharmaceuticals Holding Co., Ltd., Shanghai 200020, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914646724719018, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, authorId=1329914646594695591, language=CN, stringName=王力, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海医药集团股份有限公司,上海 200020, bio={"content":"

王力(1996—),男,硕士,从事吸入及鼻喷制剂的研究。

"}, bioImg=null, bioContent=

王力(1996—),男,硕士,从事吸入及鼻喷制剂的研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914646368203165, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, xref=1., ext=[AuthorCompanyExt(id=1329914646376591774, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, companyId=1329914646368203165, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai Pharmaceuticals Holding Co., Ltd., Shanghai 200020), AuthorCompanyExt(id=1329914646384980383, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, companyId=1329914646368203165, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海医药集团股份有限公司,上海 200020)])]), Author(id=1329914646796022188, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914646888296878, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, authorId=1329914646796022188, language=EN, stringName=Lili ZHOU, firstName=Lili, middleName=null, lastName=ZHOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.NasPress Pharmaceutical Co., Ltd., Hangzhou 311409, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914646972182959, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, authorId=1329914646796022188, language=CN, stringName=周丽丽, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.浙江信谊瑞爵制药有限公司,浙江 杭州 311409, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914646464672160, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, xref=2., ext=[AuthorCompanyExt(id=1329914646473060769, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, companyId=1329914646464672160, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.NasPress Pharmaceutical Co., Ltd., Hangzhou 311409), AuthorCompanyExt(id=1329914646477255074, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, companyId=1329914646464672160, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.浙江信谊瑞爵制药有限公司,浙江 杭州 311409)])]), Author(id=1329914647051874737, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914647127372211, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, authorId=1329914647051874737, language=EN, stringName=Yang LIU, firstName=Yang, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.Shanghai Sine Pharmaceutical Laboratories Co., Ltd., Shanghai 201206, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914647202869684, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, authorId=1329914647051874737, language=CN, stringName=刘洋, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.上海上药信谊药厂有限公司,上海 201206, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914646531781027, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, xref=3., ext=[AuthorCompanyExt(id=1329914646535975332, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, companyId=1329914646531781027, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shanghai Sine Pharmaceutical Laboratories Co., Ltd., Shanghai 201206), AuthorCompanyExt(id=1329914646540169637, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, companyId=1329914646531781027, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海上药信谊药厂有限公司,上海 201206)])]), Author(id=1329914647290950070, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=shaoqixwl@aliyun.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329914647441945016, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, authorId=1329914647290950070, language=EN, stringName=Qi SHAO, firstName=Qi, middleName=null, lastName=SHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.Shanghai Sine Pharmaceutical Laboratories Co., Ltd., Shanghai 201206, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914647500665273, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, authorId=1329914647290950070, language=CN, stringName=邵奇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.上海上药信谊药厂有限公司,上海 201206, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914646531781027, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, xref=3., ext=[AuthorCompanyExt(id=1329914646535975332, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, companyId=1329914646531781027, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shanghai Sine Pharmaceutical Laboratories Co., Ltd., Shanghai 201206), AuthorCompanyExt(id=1329914646540169637, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, companyId=1329914646531781027, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海上药信谊药厂有限公司,上海 201206)])])], keywords=[Keyword(id=1329914647597134266, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, language=EN, orderNo=1, keyword=bioequivalence), Keyword(id=1329914647668437435, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, language=EN, orderNo=2, keyword=morphologically-directed Raman spectroscopy), Keyword(id=1329914647735546301, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, language=EN, orderNo=3, keyword=particle size distribution), Keyword(id=1329914647815238078, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, language=EN, orderNo=4, keyword=suspension-based nasal spray), Keyword(id=1329914647890735551, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, language=CN, orderNo=1, keyword=生物等效性), Keyword(id=1329914647949455808, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, language=CN, orderNo=2, keyword=形态定向拉曼光谱), Keyword(id=1329914648016564673, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, language=CN, orderNo=3, keyword=粒度分布), Keyword(id=1329914648087867842, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, language=CN, orderNo=4, keyword=混悬型鼻喷剂)], refs=[Reference(id=1329914648184336835, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=NELSON M P, ZUGATES C T, TREADO P J, et al.Combining Raman chemical imaging and scanning electron microscopy to characterize ambient fine particulate matter [J].Aerosol Sci Technol, 2001, 34(1): 108-117., articleTitle=null, refAbstract=null), Reference(id=1329914648272417220, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=DOUB W H, ADAMS W P, SPENCER J A, et al.Raman chemical imaging for ingredient-specific particle size characterization of aqueous suspension nasal spray formulations: a progress report [J].Pharm Res, 2007, 24: 934-945., articleTitle=null, refAbstract=null), Reference(id=1329914648331137477, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=LEVOGUER C L, KIDDER L, HABER K.Morphologically directed Raman spectroscopy as a novel tool to monitor changes in particle size and shape in solid dosage blends and formulations [J].Sci Pharm, 2010, 78(3): 713., articleTitle=null, refAbstract=null), Reference(id=1329914648406634950, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=KINNUNEN H, HEBBINK G, PETERS H, et al.Extrinsic lactose fines improve dry powder inhaler formulation performance of a cohesive batch of budesonide via agglomerate formation and consequential co-deposition [J].Int J Pharm, 2015, 478(1): 53-59., articleTitle=null, refAbstract=null), Reference(id=1329914648469549511, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=DAS R, AGRAWAL Y.Raman spectroscopy: recent advancements, techniques and applications [J].Vib Spectrosc, 2011, 57(2): 163-176., articleTitle=null, refAbstract=null), Reference(id=1329914648574407112, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=KARKI B, FREELON B, RAJAPAKSE M, et al.Strain-induced vibrational properties of few layer black phosphorus and MoTe2 via Raman spectroscopy [J].Nanotechnology, 2020, 31(42): 425707., articleTitle=null, refAbstract=null), Reference(id=1329914648645710281, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=IBACETA-JANA J, MUYDINOV R, ROSADO P, et al.Vibrational dynamics in lead halide hybrid perovskites investigated by Raman spectroscopy [J].Phys Chem Chem Phys, 2020, 22(10): 5604-5614., articleTitle=null, refAbstract=null), Reference(id=1329914648826065355, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=YANG D Q, ZHU L Q, WANG J L, et al.Band structure and lattice vibration of elemental tellurium investigated by temperature-dependent mid-and-far infrared transmission and Raman spectroscopy [J].Phys Status Solidi, 2022, 259(7): 2100625., articleTitle=null, refAbstract=null), Reference(id=1329914648935117260, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=DOUMENG M, MAKHLOUF L, BERTHET F, et al.A comparative study of the crystallinity of polyetheretherketone by using density, DSC, XRD, and Raman spectroscopy techniques [J].Polym Test, 2021, 93: 106878., articleTitle=null, refAbstract=null), Reference(id=1329914649094500813, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=ALALI H, AI Y, PAN Y L, et al.A collection of molecular fingerprints of single aerosol particles in air for potential identification and detection using optical trapping-Raman spectroscopy [J].Molecules, 2022, 27(18): 5966., articleTitle=null, refAbstract=null), Reference(id=1329914649186775502, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=DIXON-NAISH E, PARRY M, RAMJEEAWON M, et al.New in-vitro bioequivalence approaches for generic nasal suspension products [J].J Aerosol Med Pulm Drug Delivery, 2021, 34(3): 10-11., articleTitle=null, refAbstract=null), Reference(id=1329914649253884367, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=KAMMRATH B W.Combining spectroscopy with microscopy for advancing the analysis of forensically relevant traces [J].Spectroscopy, 2020, 35(7): 33-36., articleTitle=null, refAbstract=null), Reference(id=1329914649333576144, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=KOUTRAKOS A, LEARY P, KAMMRATH, B.Illicit and counterfeit drug analysis by morphologically directed Raman spectroscopy [J].Methods Mol Biol, 2018, 1810: 13-27., articleTitle=null, refAbstract=null), Reference(id=1329914649413267921, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG S, CHEN H, LI R, et al.Raman spectroscopy and mapping technique for the identification of expired drugs [J].Spectrochim Acta Part A, 2020, 224: 117407., articleTitle=null, refAbstract=null), Reference(id=1329914649497154002, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Food and Drug Administration.Draft guidance on fluticasone furoate [EB/OL].[2023-07-10].https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_022051.pdf., articleTitle=null, refAbstract=null), Reference(id=1329914649702674899, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Food and Drug Administration.Draft guidance on mometasone furoate [EB/OL].[2023-07-10].https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_020762.pdf., articleTitle=null, refAbstract=null), Reference(id=1329914649782366676, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Food and Drug Administration.Draft guidance on azelastine hydrochloride; fluticasone propionate [EB/OL].[2023-07-10].https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_202236.PDF., articleTitle=null, refAbstract=null), Reference(id=1329914649878835669, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Food and Drug Administration.Draft guidance on mometasone furoate; olopatadine hydrochloride [EB/OL].[2023-07-10].https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_211746.pdf., articleTitle=null, refAbstract=null), Reference(id=1329914650034024918, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Food and Drug Administration.Draft guidance on fluticasone propionate [EB/OL].[2023-07-10].https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_020121.pdf., articleTitle=null, refAbstract=null), Reference(id=1329914650113716695, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Food and Drug Administration.Draft guidance on triamcinolone acetonide [EB/OL].[2023-07-10].https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_020468.pdf., articleTitle=null, refAbstract=null), Reference(id=1329914650205991384, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=VELDEMAN L, MADANI I, HULSTAERT F, et al.Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies [J].Lancet Oncol, 2008, 9(4): 367-375., articleTitle=null, refAbstract=null), Reference(id=1329914650285683161, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=BJÖRKMAN S, RIGEMAR G, IDVALL J.Pharmacokinetics of midazolam given as an intranasal spray to adult surgical patients [J].Br J Anaesth, 1997, 79(5): 575-580., articleTitle=null, refAbstract=null), Reference(id=1329914650356986330, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=KASHYAP K, SHUKLA R.Drug delivery and targeting to the brain through nasal route: mechanisms, applications and challenges [J].Curr Drug Delivery, 2019, 16(10): 887-901., articleTitle=null, refAbstract=null), Reference(id=1329914650424095195, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=KAISER H B, NACLERIO R M, GIVEN J, et al.Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis [J].J Allergy Clin Immunol, 2007, 119(6): 1430-1437., articleTitle=null, refAbstract=null), Reference(id=1329914650503786972, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=ZITT M, KOSOGLOU T, HUBBELL J.Mometasone furoate nasal spray: a review of safety and systemic effects [J].Drug Saf, 2007, 30: 317-326., articleTitle=null, refAbstract=null), Reference(id=1329914650575090141, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=CHUDIWAL S S, DEHGHAN M H G.Quality by design approach for development of suspension nasal spray products: a case study on budesonide nasal suspension [J].Drug Dev Ind Pharm, 2016, 42(10): 1643-1652., articleTitle=null, refAbstract=null), Reference(id=1329914650667364830, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=CHERVINSKY P.Clinical review of once-daily beclomethasone dipropionate for seasonal allergic rhinitis [J].Clin Ther, 1996, 18(5): 790-796., articleTitle=null, refAbstract=null), Reference(id=1329914650755445215, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Food and Drug Administration.Bioavailability and bioequivalence requirements [EB/OL].[2023-07-10].https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=320.23., articleTitle=null, refAbstract=null), Reference(id=1329914650826748384, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=SCHERLIE R.Nasal formulations for drug administration and characterization of nasal preparations in drug delivery [J].Ther Delivery, 2020, 11(3): 183-191., articleTitle=null, refAbstract=null), Reference(id=1329914650977743329, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=ANAND U, FERIDOONI T, AGU R U.Novel mucoadhesive polymers for nasal drug delivery [J].Recent Adv Novel Drug Carrier Syst, 2012, 1: 315-330., articleTitle=null, refAbstract=null), Reference(id=1329914651070018018, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=AMBRUS R, GIESZINGER P, GÁSPÁR R, et al.Investigation of the absorption of nanosized lamotrigine containing nasal powder via the nasal cavity [J].Molecules, 2020, 25(5): 1065., articleTitle=null, refAbstract=null), Reference(id=1329914651153904099, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=KUSHWAHA S K S, KESHARI R K, RAI A K.Advances in nasal trans-mucosal drug delivery [J].J Appl Pharm Sci, 2011, 1: 21-28., articleTitle=null, refAbstract=null), Reference(id=1329914651233595876, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=INOUE D, TANAKA A, KIMURA S, et al.The relationship between in vivo nasal drug clearance and in vitro nasal mucociliary clearance: application to the prediction of nasal drug absorption [J].Eur J Pharm Sci, 2018, 117: 21-26., articleTitle=null, refAbstract=null), Reference(id=1329914651321676261, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN J, MARTIN A R, FINLAY W H.Recent in vitro and in silico advances in the understanding of intranasal drug delivery [J].Curr Pharm Des, 2021, 27(12): 1482-1497., articleTitle=null, refAbstract=null), Reference(id=1329914651401368038, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=ERRECALDE J, LIFSCHITZ A, VECCHIOLI G, et al.Safety and pharmacokinetic assessments of a novel ivermectin nasal spray formulation in a pig model [J].J Pharm Sci, 2021, 110(6): 2501-2507., articleTitle=null, refAbstract=null), Reference(id=1329914651485254119, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=BARTOS C, SZABÓ-RÉVÉSZ P, HORVÁTH T, et al.Comparison of modern in vitro permeability methods with the aim of investigation nasal dosage forms [J].Pharmaceutics, 2021, 13(6): 846., articleTitle=null, refAbstract=null), Reference(id=1329914651548168680, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=CHARI S, SRIDHAR K, WALENGA R, et al.Computational analysis of a 3D mucociliary clearance model predicting nasal drug uptake [J].J Aerosol Sci, 2021, 155: 105757., articleTitle=null, refAbstract=null), Reference(id=1329914651661414889, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=LE GUELLEC S, EHRMANN S, VECELLIO L.In vitro-in vivo correlation of intranasal drug deposition [J].Adv Drug Delivery Rev, 2021, 170: 340-352., articleTitle=null, refAbstract=null), Reference(id=1329914651728523754, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=Food and Drug Administration.FDA embraces emerging technology for bioequivalence evaluation of locally acting nasal sprays [EB/OL].[2023-07-10].https://www.fda.gov/media/97705/download., articleTitle=null, refAbstract=null), Reference(id=1329914651795632619, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=Food and Drug Administration.Draft guidance on budesonide[EB/OL].[2023-07-10].https://www.accessdata.fda.gov/drugsatfda_docs/psg/Budeso nide_Inhalation_Sus_20929_RC_09-12.pdf., articleTitle=null, refAbstract=null), Reference(id=1329914651879518701, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=LI B V, JIN F, LEE S L, et al.Bioequivalence for locally acting nasal spray and nasal aerosol products: standard development and generic approval [J].AAPS J, 2013, 15: 875-883., articleTitle=null, refAbstract=null), Reference(id=1329914651967599086, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU Q, ABSAR M, SALUJA B, et al.Scientific considerations for the review and approval of first generic mometasone furoate nasal suspension spray in the United States from the bioequivalence perspective [J].AAPS J, 2019, 21: 14., articleTitle=null, refAbstract=null), Reference(id=1329914652026319343, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=SHARPE S A, SANDWEISS V, TUAZON J, et al.Comparison of the flow properties of aqueous suspension corticosteroid nasal sprays under differing sampling conditions [J].Drug Dev Ind Pharm, 2003, 29(9): 1005-1012., articleTitle=null, refAbstract=null), Reference(id=1329914652093428208, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=Food and Drug Administration.Common bioequivalence deficiencies of morphologically directed Raman spectroscopy study in generic orally inhaled and nasal drug products [EB/OL].[2023-07-10].https://www.fda.gov/media/168945/download., articleTitle=null, refAbstract=null), Reference(id=1329914652160537073, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU S.Particle dispersion for suspension flow [J].Chem Eng Sci, 1999, 54(7): 873-891., articleTitle=null, refAbstract=null), Reference(id=1329914652252811762, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=GROBUSCHEK N, LECNIK O, SCHMID M G, et al.Mass uniformity of nasal sprays [J].Sci Pharm, 2003, 71(3): 151-164., articleTitle=null, refAbstract=null), Reference(id=1329914652324114931, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=PU Y, MEDENDORP J P, YONZON C R.Real-time monitoring of active ingredient dispersion in a pharmaceutical aqueous suspension using Raman spectroscopy [J].J Raman Spectrosc, 2011, 42(11): 1994-1999., articleTitle=null, refAbstract=null), Reference(id=1329914652428972532, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=BRANDON J, MOHAMMAD A, RENISHKUMAR D, et al.Analytical method development for characterizing ingredient-specific particle size distributions of nasal spray suspension products [J].J Pharm Sci, 2021, 110(7): 2778-2788., articleTitle=null, refAbstract=null), Reference(id=1329914652500275701, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=MALVERN P.Morphologi 4 user manual [EB/OL].[2023-07-10].https://www.malvernpanalytical.com//en/learn/knowledge-center/user-manuals/man0595en., articleTitle=null, refAbstract=null), Reference(id=1329914652579967478, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=CLARKE J, GAMBLE J F, JONES J W, et al.Alternative approach for defining the particle population requirements for static image analysis based particle characterization methods[J].Adv Powder Technol, 2019, 30(5): 920-929., articleTitle=null, refAbstract=null), Reference(id=1329914652655464951, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG H, BORAEY M A, WILLIAMS L, et al.Low-frequency shift dispersive Raman spectroscopy for the analysis of respirable dosage forms [J].Int J Pharm, 2014, 469(1): 197-205., articleTitle=null, refAbstract=null), Reference(id=1329914652718379512, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG T, DAI L.Background subtraction of Raman spectra based on iterative polynomial smoothing [J].Appl Spectrosc, 2017, 71(6): 1169-1179., articleTitle=null, refAbstract=null), Reference(id=1329914652777099769, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=MIKLI V, KAERDI H, KULU P, et al.Characterization of powder particle morphology [J].Proc Est Acad Sci Eng, 2001, 7(1): 22-34., articleTitle=null, refAbstract=null), Reference(id=1329914652844208634, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=FARIAS G, SHUR J, PRICE R, et al.A systematic approach in the development of the morphologically-directed Raman spectroscopy methodology for characterizing nasal suspension drug products [J].AAPS J, 2021, 23: 73., articleTitle=null, refAbstract=null), Reference(id=1329914652911317499, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[55], rfOrder=54, authorNames=null, journalName=null, refType=null, unstructuredReference=FARIAS G, HUCK-JONES R P D, SHUR J.Investigating orthogonal in vitro analytical approaches to demonstrate bioequivalence of nasal suspension formulations [J].J Pulm Drug Delivery, 2018, 31(2): 30-31., articleTitle=null, refAbstract=null), Reference(id=1329914652970037756, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[56], rfOrder=55, authorNames=null, journalName=null, refType=null, unstructuredReference=LANGER J, JIMENEZ DE ABERASTURI D, AIZPURUA J,et al.Present and future of surface-enhanced Raman scattering [J].ACS Nano, 2019, 14(1): 28-117., articleTitle=null, refAbstract=null), Reference(id=1329914653079089661, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[57], rfOrder=56, authorNames=null, journalName=null, refType=null, unstructuredReference=DUTTA A.Fourier transform infrared spectroscopy [J].Spect Meth Nano Char, 2017, 1: 73-93., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329914646368203165, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, xref=1., ext=[AuthorCompanyExt(id=1329914646376591774, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, companyId=1329914646368203165, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai Pharmaceuticals Holding Co., Ltd., Shanghai 200020), AuthorCompanyExt(id=1329914646384980383, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, companyId=1329914646368203165, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海医药集团股份有限公司,上海 200020)]), AuthorCompany(id=1329914646464672160, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, xref=2., ext=[AuthorCompanyExt(id=1329914646473060769, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, companyId=1329914646464672160, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.NasPress Pharmaceutical Co., Ltd., Hangzhou 311409), AuthorCompanyExt(id=1329914646477255074, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, companyId=1329914646464672160, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.浙江信谊瑞爵制药有限公司,浙江 杭州 311409)]), AuthorCompany(id=1329914646531781027, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, xref=3., ext=[AuthorCompanyExt(id=1329914646535975332, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, companyId=1329914646531781027, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shanghai Sine Pharmaceutical Laboratories Co., Ltd., Shanghai 201206), AuthorCompanyExt(id=1329914646540169637, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, companyId=1329914646531781027, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海上药信谊药厂有限公司,上海 201206)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.07.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.07.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2024.07.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2024.07.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1720540800000, fullTextJson=null, articleText=null, reference=null)
收藏切换
形态定向拉曼光谱检测在混悬型鼻喷剂生物等效性研究中的应用
王力 1 , 周丽丽 2 , 刘洋 3 , 邵奇 3, *
中国医药工业杂志 | 专论 2024,55(7): 887-899
收起
收藏切换
中国医药工业杂志 |专论 2024 , 55 (7) : 887 -899
形态定向拉曼光谱检测在混悬型鼻喷剂生物等效性研究中的应用
全屏
[Author(id=1329914646594695591, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914646657610153, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, authorId=1329914646594695591, language=EN, stringName=Li WANG, firstName=Li, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Shanghai Pharmaceuticals Holding Co., Ltd., Shanghai 200020, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914646724719018, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, authorId=1329914646594695591, language=CN, stringName=王力, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海医药集团股份有限公司,上海 200020, bio={"content":"

王力(1996—),男,硕士,从事吸入及鼻喷制剂的研究。

"}, bioImg=null, bioContent=

王力(1996—),男,硕士,从事吸入及鼻喷制剂的研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914646368203165, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, xref=1., ext=[AuthorCompanyExt(id=1329914646376591774, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, companyId=1329914646368203165, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Shanghai Pharmaceuticals Holding Co., Ltd., Shanghai 200020), AuthorCompanyExt(id=1329914646384980383, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, companyId=1329914646368203165, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海医药集团股份有限公司,上海 200020)])]), Author(id=1329914646796022188, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914646888296878, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, authorId=1329914646796022188, language=EN, stringName=Lili ZHOU, firstName=Lili, middleName=null, lastName=ZHOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.NasPress Pharmaceutical Co., Ltd., Hangzhou 311409, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914646972182959, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, authorId=1329914646796022188, language=CN, stringName=周丽丽, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.浙江信谊瑞爵制药有限公司,浙江 杭州 311409, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914646464672160, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, xref=2., ext=[AuthorCompanyExt(id=1329914646473060769, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, companyId=1329914646464672160, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.NasPress Pharmaceutical Co., Ltd., Hangzhou 311409), AuthorCompanyExt(id=1329914646477255074, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, companyId=1329914646464672160, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.浙江信谊瑞爵制药有限公司,浙江 杭州 311409)])]), Author(id=1329914647051874737, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914647127372211, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, authorId=1329914647051874737, language=EN, stringName=Yang LIU, firstName=Yang, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.Shanghai Sine Pharmaceutical Laboratories Co., Ltd., Shanghai 201206, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914647202869684, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, authorId=1329914647051874737, language=CN, stringName=刘洋, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.上海上药信谊药厂有限公司,上海 201206, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914646531781027, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, xref=3., ext=[AuthorCompanyExt(id=1329914646535975332, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, companyId=1329914646531781027, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shanghai Sine Pharmaceutical Laboratories Co., Ltd., Shanghai 201206), AuthorCompanyExt(id=1329914646540169637, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, companyId=1329914646531781027, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海上药信谊药厂有限公司,上海 201206)])]), Author(id=1329914647290950070, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=shaoqixwl@aliyun.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329914647441945016, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, authorId=1329914647290950070, language=EN, stringName=Qi SHAO, firstName=Qi, middleName=null, lastName=SHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.Shanghai Sine Pharmaceutical Laboratories Co., Ltd., Shanghai 201206, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914647500665273, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, authorId=1329914647290950070, language=CN, stringName=邵奇, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.上海上药信谊药厂有限公司,上海 201206, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914646531781027, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, xref=3., ext=[AuthorCompanyExt(id=1329914646535975332, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, companyId=1329914646531781027, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shanghai Sine Pharmaceutical Laboratories Co., Ltd., Shanghai 201206), AuthorCompanyExt(id=1329914646540169637, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914644648538520, companyId=1329914646531781027, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海上药信谊药厂有限公司,上海 201206)])])]
王力1, 周丽丽2, 刘洋3, 邵奇3, *
作者信息
  • 1.上海医药集团股份有限公司,上海 200020
  • 2.浙江信谊瑞爵制药有限公司,浙江 杭州 311409
  • 3.上海上药信谊药厂有限公司,上海 201206
通讯作者:
邵奇(1986—),男,硕士生导师,从事吸入及液体制剂的研究与开发。E-mail:
作者简介:

邵奇,高级工程师,市级青年领军人才。2008年入职上药信谊药物研究所,现担任所长助理。曾荣获全国五一劳动奖章,市级以上相关荣誉5项。现兼职担任中国颗粒学会吸入颗粒专业委员会秘书长、上海理工大学硕士生导师等职务。主要研究方向为吸入制剂、注射液、口服液等产品的研发与产业化工作。在职期间,带领团队获国家药品监督管理局批准产品生产批件共计10项,其中气雾剂4项,雾化吸入剂2项,注射液4项;吸入制剂临床批件2项;其他在研吸入制剂(含鼻喷)6项,口服混悬液1项,软胶囊制剂2项等。在美国FDA完成申报鼻喷剂项目1项。作为第二主译参与《经口吸入产品的级联撞击器理论与实践》的编译、出版。国家授权专利11项。

王力(1996—),男,硕士,从事吸入及鼻喷制剂的研究。

Application of Morphologically-directed Raman Spectroscopy in the Bioequivalence Study of Suspension-based Nasal Spray
Li WANG1, Lili ZHOU2, Yang LIU3, Qi SHAO3, *
Affiliations
  • 1.Shanghai Pharmaceuticals Holding Co., Ltd., Shanghai 200020
  • 2.NasPress Pharmaceutical Co., Ltd., Hangzhou 311409
  • 3.Shanghai Sine Pharmaceutical Laboratories Co., Ltd., Shanghai 201206
出版时间: 2024-07-10 doi: 10.16522/j.cnki.cjph.2024.07.001
文章导航
收藏切换

混悬型鼻用喷雾剂的生物等效性研究对于仿制药开发者而言是一项具有挑战性的任务。研究者不仅要按照指导原则的要求,对辅料用量和制剂特性进行一致性研究,更需要通过分析工具来确定活性药物成分的粒径大小、粒度分布等关键质量属性的一致性。该文探讨了形态定向拉曼光谱法在研究鼻腔悬浮液粒度分布中的应用。该方法已被美国FDA批准用于替代临床终点生物等效性的研究,对降低混悬型鼻用喷雾剂类产品一致性评价的成本、加快其研发速度有重要作用。

生物等效性  /  形态定向拉曼光谱  /  粒度分布  /  混悬型鼻喷剂

Bioequivalence studies of suspension-based nasal sprays are challenging tasks for generic drug developers. Researchers should not only conduct consistency studies on the dosage and formulation characteristics of excipients in accordance with the requirements of the guidelines, but also need to use analytical tools to determine the consistency of key quality attributes such as particle size and particle size distribution of active pharmaceutical ingredients. This study explored the application of morphologically-directed Raman spectroscopy in the study of particle size distribution of nasal suspensions. The method has been approved by the U.S. FDA for the studies that substitute bioequivalence of clinical endpoints, which is critical for cost reduction and faster development for consistency evaluation of suspension-based nasal spray products.

bioequivalence  /  morphologically-directed Raman spectroscopy  /  particle size distribution  /  suspension-based nasal spray
王力, 周丽丽, 刘洋, 邵奇. 形态定向拉曼光谱检测在混悬型鼻喷剂生物等效性研究中的应用. 中国医药工业杂志, 2024 , 55 (7) : 887 -899 . DOI: 10.16522/j.cnki.cjph.2024.07.001
Li WANG, Lili ZHOU, Yang LIU, Qi SHAO. Application of Morphologically-directed Raman Spectroscopy in the Bioequivalence Study of Suspension-based Nasal Spray[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (7) : 887 -899 . DOI: 10.16522/j.cnki.cjph.2024.07.001

参考文献 引证文献
排序方式:
[1]
NELSON M P, ZUGATES C T, TREADO P J, et al.Combining Raman chemical imaging and scanning electron microscopy to characterize ambient fine particulate matter [J].Aerosol Sci Technol, 2001, 34(1): 108-117.
[2]
DOUB W H, ADAMS W P, SPENCER J A, et al.Raman chemical imaging for ingredient-specific particle size characterization of aqueous suspension nasal spray formulations: a progress report [J].Pharm Res, 2007, 24: 934-945.
[3]
LEVOGUER C L, KIDDER L, HABER K.Morphologically directed Raman spectroscopy as a novel tool to monitor changes in particle size and shape in solid dosage blends and formulations [J].Sci Pharm, 2010, 78(3): 713.
[4]
KINNUNEN H, HEBBINK G, PETERS H, et al.Extrinsic lactose fines improve dry powder inhaler formulation performance of a cohesive batch of budesonide via agglomerate formation and consequential co-deposition [J].Int J Pharm, 2015, 478(1): 53-59.
[5]
DAS R, AGRAWAL Y.Raman spectroscopy: recent advancements, techniques and applications [J].Vib Spectrosc, 2011, 57(2): 163-176.
[6]
KARKI B, FREELON B, RAJAPAKSE M, et al.Strain-induced vibrational properties of few layer black phosphorus and MoTe2 via Raman spectroscopy [J].Nanotechnology, 2020, 31(42): 425707.
[7]
IBACETA-JANA J, MUYDINOV R, ROSADO P, et al.Vibrational dynamics in lead halide hybrid perovskites investigated by Raman spectroscopy [J].Phys Chem Chem Phys, 2020, 22(10): 5604-5614.
[8]
YANG D Q, ZHU L Q, WANG J L, et al.Band structure and lattice vibration of elemental tellurium investigated by temperature-dependent mid-and-far infrared transmission and Raman spectroscopy [J].Phys Status Solidi, 2022, 259(7): 2100625.
[9]
DOUMENG M, MAKHLOUF L, BERTHET F, et al.A comparative study of the crystallinity of polyetheretherketone by using density, DSC, XRD, and Raman spectroscopy techniques [J].Polym Test, 2021, 93: 106878.
[10]
ALALI H, AI Y, PAN Y L, et al.A collection of molecular fingerprints of single aerosol particles in air for potential identification and detection using optical trapping-Raman spectroscopy [J].Molecules, 2022, 27(18): 5966.
[11]
DIXON-NAISH E, PARRY M, RAMJEEAWON M, et al.New in-vitro bioequivalence approaches for generic nasal suspension products [J].J Aerosol Med Pulm Drug Delivery, 2021, 34(3): 10-11.
[12]
KAMMRATH B W.Combining spectroscopy with microscopy for advancing the analysis of forensically relevant traces [J].Spectroscopy, 2020, 35(7): 33-36.
[13]
KOUTRAKOS A, LEARY P, KAMMRATH, B.Illicit and counterfeit drug analysis by morphologically directed Raman spectroscopy [J].Methods Mol Biol, 2018, 1810: 13-27.
[14]
ZHANG S, CHEN H, LI R, et al.Raman spectroscopy and mapping technique for the identification of expired drugs [J].Spectrochim Acta Part A, 2020, 224: 117407.
[15]
Food and Drug Administration.Draft guidance on fluticasone furoate [EB/OL].[2023-07-10].https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_022051.pdf.
[16]
Food and Drug Administration.Draft guidance on mometasone furoate [EB/OL].[2023-07-10].https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_020762.pdf.
[17]
Food and Drug Administration.Draft guidance on azelastine hydrochloride; fluticasone propionate [EB/OL].[2023-07-10].https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_202236.PDF.
[18]
Food and Drug Administration.Draft guidance on mometasone furoate; olopatadine hydrochloride [EB/OL].[2023-07-10].https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_211746.pdf.
[19]
Food and Drug Administration.Draft guidance on fluticasone propionate [EB/OL].[2023-07-10].https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_020121.pdf.
[20]
Food and Drug Administration.Draft guidance on triamcinolone acetonide [EB/OL].[2023-07-10].https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_020468.pdf.
[21]
VELDEMAN L, MADANI I, HULSTAERT F, et al.Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies [J].Lancet Oncol, 2008, 9(4): 367-375.
[22]
BJÖRKMAN S, RIGEMAR G, IDVALL J.Pharmacokinetics of midazolam given as an intranasal spray to adult surgical patients [J].Br J Anaesth, 1997, 79(5): 575-580.
[23]
KASHYAP K, SHUKLA R.Drug delivery and targeting to the brain through nasal route: mechanisms, applications and challenges [J].Curr Drug Delivery, 2019, 16(10): 887-901.
[24]
KAISER H B, NACLERIO R M, GIVEN J, et al.Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis [J].J Allergy Clin Immunol, 2007, 119(6): 1430-1437.
[25]
ZITT M, KOSOGLOU T, HUBBELL J.Mometasone furoate nasal spray: a review of safety and systemic effects [J].Drug Saf, 2007, 30: 317-326.
[26]
CHUDIWAL S S, DEHGHAN M H G.Quality by design approach for development of suspension nasal spray products: a case study on budesonide nasal suspension [J].Drug Dev Ind Pharm, 2016, 42(10): 1643-1652.
[27]
CHERVINSKY P.Clinical review of once-daily beclomethasone dipropionate for seasonal allergic rhinitis [J].Clin Ther, 1996, 18(5): 790-796.
[28]
Food and Drug Administration.Bioavailability and bioequivalence requirements [EB/OL].[2023-07-10].https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=320.23.
[29]
SCHERLIE R.Nasal formulations for drug administration and characterization of nasal preparations in drug delivery [J].Ther Delivery, 2020, 11(3): 183-191.
[30]
ANAND U, FERIDOONI T, AGU R U.Novel mucoadhesive polymers for nasal drug delivery [J].Recent Adv Novel Drug Carrier Syst, 2012, 1: 315-330.
[31]
AMBRUS R, GIESZINGER P, GÁSPÁR R, et al.Investigation of the absorption of nanosized lamotrigine containing nasal powder via the nasal cavity [J].Molecules, 2020, 25(5): 1065.
[32]
KUSHWAHA S K S, KESHARI R K, RAI A K.Advances in nasal trans-mucosal drug delivery [J].J Appl Pharm Sci, 2011, 1: 21-28.
[33]
INOUE D, TANAKA A, KIMURA S, et al.The relationship between in vivo nasal drug clearance and in vitro nasal mucociliary clearance: application to the prediction of nasal drug absorption [J].Eur J Pharm Sci, 2018, 117: 21-26.
[34]
CHEN J, MARTIN A R, FINLAY W H.Recent in vitro and in silico advances in the understanding of intranasal drug delivery [J].Curr Pharm Des, 2021, 27(12): 1482-1497.
[35]
ERRECALDE J, LIFSCHITZ A, VECCHIOLI G, et al.Safety and pharmacokinetic assessments of a novel ivermectin nasal spray formulation in a pig model [J].J Pharm Sci, 2021, 110(6): 2501-2507.
[36]
BARTOS C, SZABÓ-RÉVÉSZ P, HORVÁTH T, et al.Comparison of modern in vitro permeability methods with the aim of investigation nasal dosage forms [J].Pharmaceutics, 2021, 13(6): 846.
[37]
CHARI S, SRIDHAR K, WALENGA R, et al.Computational analysis of a 3D mucociliary clearance model predicting nasal drug uptake [J].J Aerosol Sci, 2021, 155: 105757.
[38]
LE GUELLEC S, EHRMANN S, VECELLIO L.In vitro-in vivo correlation of intranasal drug deposition [J].Adv Drug Delivery Rev, 2021, 170: 340-352.
[39]
Food and Drug Administration.FDA embraces emerging technology for bioequivalence evaluation of locally acting nasal sprays [EB/OL].[2023-07-10].https://www.fda.gov/media/97705/download.
[40]
Food and Drug Administration.Draft guidance on budesonide[EB/OL].[2023-07-10].https://www.accessdata.fda.gov/drugsatfda_docs/psg/Budeso nide_Inhalation_Sus_20929_RC_09-12.pdf.
[41]
LI B V, JIN F, LEE S L, et al.Bioequivalence for locally acting nasal spray and nasal aerosol products: standard development and generic approval [J].AAPS J, 2013, 15: 875-883.
[42]
LIU Q, ABSAR M, SALUJA B, et al.Scientific considerations for the review and approval of first generic mometasone furoate nasal suspension spray in the United States from the bioequivalence perspective [J].AAPS J, 2019, 21: 14.
[43]
SHARPE S A, SANDWEISS V, TUAZON J, et al.Comparison of the flow properties of aqueous suspension corticosteroid nasal sprays under differing sampling conditions [J].Drug Dev Ind Pharm, 2003, 29(9): 1005-1012.
[44]
Food and Drug Administration.Common bioequivalence deficiencies of morphologically directed Raman spectroscopy study in generic orally inhaled and nasal drug products [EB/OL].[2023-07-10].https://www.fda.gov/media/168945/download.
[45]
LIU S.Particle dispersion for suspension flow [J].Chem Eng Sci, 1999, 54(7): 873-891.
[46]
GROBUSCHEK N, LECNIK O, SCHMID M G, et al.Mass uniformity of nasal sprays [J].Sci Pharm, 2003, 71(3): 151-164.
[47]
PU Y, MEDENDORP J P, YONZON C R.Real-time monitoring of active ingredient dispersion in a pharmaceutical aqueous suspension using Raman spectroscopy [J].J Raman Spectrosc, 2011, 42(11): 1994-1999.
[48]
BRANDON J, MOHAMMAD A, RENISHKUMAR D, et al.Analytical method development for characterizing ingredient-specific particle size distributions of nasal spray suspension products [J].J Pharm Sci, 2021, 110(7): 2778-2788.
[49]
MALVERN P.Morphologi 4 user manual [EB/OL].[2023-07-10].https://www.malvernpanalytical.com//en/learn/knowledge-center/user-manuals/man0595en.
[50]
CLARKE J, GAMBLE J F, JONES J W, et al.Alternative approach for defining the particle population requirements for static image analysis based particle characterization methods[J].Adv Powder Technol, 2019, 30(5): 920-929.
[51]
WANG H, BORAEY M A, WILLIAMS L, et al.Low-frequency shift dispersive Raman spectroscopy for the analysis of respirable dosage forms [J].Int J Pharm, 2014, 469(1): 197-205.
[52]
WANG T, DAI L.Background subtraction of Raman spectra based on iterative polynomial smoothing [J].Appl Spectrosc, 2017, 71(6): 1169-1179.
[53]
MIKLI V, KAERDI H, KULU P, et al.Characterization of powder particle morphology [J].Proc Est Acad Sci Eng, 2001, 7(1): 22-34.
[54]
FARIAS G, SHUR J, PRICE R, et al.A systematic approach in the development of the morphologically-directed Raman spectroscopy methodology for characterizing nasal suspension drug products [J].AAPS J, 2021, 23: 73.
[55]
FARIAS G, HUCK-JONES R P D, SHUR J.Investigating orthogonal in vitro analytical approaches to demonstrate bioequivalence of nasal suspension formulations [J].J Pulm Drug Delivery, 2018, 31(2): 30-31.
[56]
LANGER J, JIMENEZ DE ABERASTURI D, AIZPURUA J,et al.Present and future of surface-enhanced Raman scattering [J].ACS Nano, 2019, 14(1): 28-117.
[57]
DUTTA A.Fourier transform infrared spectroscopy [J].Spect Meth Nano Char, 2017, 1: 73-93.
2024年第55卷第7期
27
6
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2024.07.001
  • 接收时间:2023-08-29
  • 首发时间:2026-11-18
  • 出版时间:2024-07-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-08-29
基金
作者信息
    1.上海医药集团股份有限公司,上海 200020
    2.浙江信谊瑞爵制药有限公司,浙江 杭州 311409
    3.上海上药信谊药厂有限公司,上海 201206

通讯作者:

邵奇(1986—),男,硕士生导师,从事吸入及液体制剂的研究与开发。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.07.001
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏